The global market for Colorectal Cancer Diagnosis and Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Colorectal Cancer Diagnosis and Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Colorectal Cancer Diagnosis and Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Colorectal Cancer Diagnosis and Therapeutics in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Colorectal Cancer Diagnosis and Therapeutics include Abbott, Beckman Coulter, Clinical Genomics, Volition RX, EDP Biotech, Epigenomics, Novigenix, Siemens, Quest Diagnostics, Metabiomics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Colorectal Cancer Diagnosis and Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colorectal Cancer Diagnosis and Therapeutics.

The Colorectal Cancer Diagnosis and Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Colorectal Cancer Diagnosis and Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Colorectal Cancer Diagnosis and Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Colorectal Cancer Diagnosis and Therapeutics Market Report

Report Metric	Details
Report Name	Colorectal Cancer Diagnosis and Therapeutics Market
Segment by Type	Diagnostics Therapeutics
Segment by Application	Hospitals Diagnostic centres Research institutions
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott, Beckman Coulter, Clinical Genomics, Volition RX, EDP Biotech, Epigenomics, Novigenix, Siemens, Quest Diagnostics, Metabiomics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Colorectal Cancer Diagnosis and Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Colorectal Cancer Diagnosis and Therapeutics Market report?

Ans: The main players in the Colorectal Cancer Diagnosis and Therapeutics Market are Abbott, Beckman Coulter, Clinical Genomics, Volition RX, EDP Biotech, Epigenomics, Novigenix, Siemens, Quest Diagnostics, Metabiomics

What are the Application segmentation covered in the Colorectal Cancer Diagnosis and Therapeutics Market report?

Ans: The Applications covered in the Colorectal Cancer Diagnosis and Therapeutics Market report are Hospitals, Diagnostic centres, Research institutions

What are the Type segmentation covered in the Colorectal Cancer Diagnosis and Therapeutics Market report?

Ans: The Types covered in the Colorectal Cancer Diagnosis and Therapeutics Market report are Diagnostics, Therapeutics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Colorectal Cancer Diagnosis and Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Diagnostics

1.2.3 Therapeutics

1.3 Market by Application

1.3.1 Global Colorectal Cancer Diagnosis and Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Diagnostic centres

1.3.4 Research institutions

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Colorectal Cancer Diagnosis and Therapeutics Market Perspective (2020-2031)

2.2 Global Colorectal Cancer Diagnosis and Therapeutics Growth Trends by Region

2.2.1 Global Colorectal Cancer Diagnosis and Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Colorectal Cancer Diagnosis and Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Colorectal Cancer Diagnosis and Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Colorectal Cancer Diagnosis and Therapeutics Market Dynamics

2.3.1 Colorectal Cancer Diagnosis and Therapeutics Industry Trends

2.3.2 Colorectal Cancer Diagnosis and Therapeutics Market Drivers

2.3.3 Colorectal Cancer Diagnosis and Therapeutics Market Challenges

2.3.4 Colorectal Cancer Diagnosis and Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Colorectal Cancer Diagnosis and Therapeutics Players by Revenue

3.1.1 Global Top Colorectal Cancer Diagnosis and Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Colorectal Cancer Diagnosis and Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Colorectal Cancer Diagnosis and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Colorectal Cancer Diagnosis and Therapeutics Revenue

3.4 Global Colorectal Cancer Diagnosis and Therapeutics Market Concentration Ratio

3.4.1 Global Colorectal Cancer Diagnosis and Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Diagnosis and Therapeutics Revenue in 2024

3.5 Global Key Players of Colorectal Cancer Diagnosis and Therapeutics Head office and Area Served

3.6 Global Key Players of Colorectal Cancer Diagnosis and Therapeutics, Product and Application

3.7 Global Key Players of Colorectal Cancer Diagnosis and Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Colorectal Cancer Diagnosis and Therapeutics Breakdown Data by Type

4.1 Global Colorectal Cancer Diagnosis and Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Colorectal Cancer Diagnosis and Therapeutics Forecasted Market Size by Type (2026-2031)

5 Colorectal Cancer Diagnosis and Therapeutics Breakdown Data by Application

5.1 Global Colorectal Cancer Diagnosis and Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Colorectal Cancer Diagnosis and Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Colorectal Cancer Diagnosis and Therapeutics Market Size (2020-2031)

6.2 North America Colorectal Cancer Diagnosis and Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2020-2025)

6.4 North America Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Colorectal Cancer Diagnosis and Therapeutics Market Size (2020-2031)

7.2 Europe Colorectal Cancer Diagnosis and Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2020-2025)

7.4 Europe Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Colorectal Cancer Diagnosis and Therapeutics Market Size (2020-2031)

9.2 Latin America Colorectal Cancer Diagnosis and Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott

11.1.1 Abbott Company Details

11.1.2 Abbott Business Overview

11.1.3 Abbott Colorectal Cancer Diagnosis and Therapeutics Introduction

11.1.4 Abbott Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2020-2025)

11.1.5 Abbott Recent Development

11.2 Beckman Coulter

11.2.1 Beckman Coulter Company Details

11.2.2 Beckman Coulter Business Overview

11.2.3 Beckman Coulter Colorectal Cancer Diagnosis and Therapeutics Introduction

11.2.4 Beckman Coulter Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2020-2025)

11.2.5 Beckman Coulter Recent Development

11.3 Clinical Genomics

11.3.1 Clinical Genomics Company Details

11.3.2 Clinical Genomics Business Overview

11.3.3 Clinical Genomics Colorectal Cancer Diagnosis and Therapeutics Introduction

11.3.4 Clinical Genomics Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2020-2025)

11.3.5 Clinical Genomics Recent Development

11.4 Volition RX

11.4.1 Volition RX Company Details

11.4.2 Volition RX Business Overview

11.4.3 Volition RX Colorectal Cancer Diagnosis and Therapeutics Introduction

11.4.4 Volition RX Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2020-2025)

11.4.5 Volition RX Recent Development

11.5 EDP Biotech

11.5.1 EDP Biotech Company Details

11.5.2 EDP Biotech Business Overview

11.5.3 EDP Biotech Colorectal Cancer Diagnosis and Therapeutics Introduction

11.5.4 EDP Biotech Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2020-2025)

11.5.5 EDP Biotech Recent Development

11.6 Epigenomics

11.6.1 Epigenomics Company Details

11.6.2 Epigenomics Business Overview

11.6.3 Epigenomics Colorectal Cancer Diagnosis and Therapeutics Introduction

11.6.4 Epigenomics Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2020-2025)

11.6.5 Epigenomics Recent Development

11.7 Novigenix

11.7.1 Novigenix Company Details

11.7.2 Novigenix Business Overview

11.7.3 Novigenix Colorectal Cancer Diagnosis and Therapeutics Introduction

11.7.4 Novigenix Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2020-2025)

11.7.5 Novigenix Recent Development

11.8 Siemens

11.8.1 Siemens Company Details

11.8.2 Siemens Business Overview

11.8.3 Siemens Colorectal Cancer Diagnosis and Therapeutics Introduction

11.8.4 Siemens Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2020-2025)

11.8.5 Siemens Recent Development

11.9 Quest Diagnostics

11.9.1 Quest Diagnostics Company Details

11.9.2 Quest Diagnostics Business Overview

11.9.3 Quest Diagnostics Colorectal Cancer Diagnosis and Therapeutics Introduction

11.9.4 Quest Diagnostics Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2020-2025)

11.9.5 Quest Diagnostics Recent Development

11.10 Metabiomics

11.10.1 Metabiomics Company Details

11.10.2 Metabiomics Business Overview

11.10.3 Metabiomics Colorectal Cancer Diagnosis and Therapeutics Introduction

11.10.4 Metabiomics Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2020-2025)

11.10.5 Metabiomics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Colorectal Cancer Diagnosis and Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Diagnostics

Table 3. Key Players of Therapeutics

Table 4. Global Colorectal Cancer Diagnosis and Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Colorectal Cancer Diagnosis and Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Colorectal Cancer Diagnosis and Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Colorectal Cancer Diagnosis and Therapeutics Market Share by Region (2020-2025)

Table 8. Global Colorectal Cancer Diagnosis and Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Colorectal Cancer Diagnosis and Therapeutics Market Share by Region (2026-2031)

Table 10. Colorectal Cancer Diagnosis and Therapeutics Market Trends

Table 11. Colorectal Cancer Diagnosis and Therapeutics Market Drivers

Table 12. Colorectal Cancer Diagnosis and Therapeutics Market Challenges

Table 13. Colorectal Cancer Diagnosis and Therapeutics Market Restraints

Table 14. Global Colorectal Cancer Diagnosis and Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Colorectal Cancer Diagnosis and Therapeutics Market Share by Players (2020-2025)

Table 16. Global Top Colorectal Cancer Diagnosis and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Diagnosis and Therapeutics as of 2024)

Table 17. Ranking of Global Top Colorectal Cancer Diagnosis and Therapeutics Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Colorectal Cancer Diagnosis and Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Colorectal Cancer Diagnosis and Therapeutics, Headquarters and Area Served

Table 20. Global Key Players of Colorectal Cancer Diagnosis and Therapeutics, Product and Application

Table 21. Global Key Players of Colorectal Cancer Diagnosis and Therapeutics, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Colorectal Cancer Diagnosis and Therapeutics Revenue Market Share by Type (2020-2025)

Table 25. Global Colorectal Cancer Diagnosis and Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Colorectal Cancer Diagnosis and Therapeutics Revenue Market Share by Type (2026-2031)

Table 27. Global Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Colorectal Cancer Diagnosis and Therapeutics Revenue Market Share by Application (2020-2025)

Table 29. Global Colorectal Cancer Diagnosis and Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Colorectal Cancer Diagnosis and Therapeutics Revenue Market Share by Application (2026-2031)

Table 31. North America Colorectal Cancer Diagnosis and Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Colorectal Cancer Diagnosis and Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Colorectal Cancer Diagnosis and Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 46. Abbott Company Details

Table 47. Abbott Business Overview

Table 48. Abbott Colorectal Cancer Diagnosis and Therapeutics Product

Table 49. Abbott Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2020-2025) & (US$ Million)

Table 50. Abbott Recent Development

Table 51. Beckman Coulter Company Details

Table 52. Beckman Coulter Business Overview

Table 53. Beckman Coulter Colorectal Cancer Diagnosis and Therapeutics Product

Table 54. Beckman Coulter Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2020-2025) & (US$ Million)

Table 55. Beckman Coulter Recent Development

Table 56. Clinical Genomics Company Details

Table 57. Clinical Genomics Business Overview

Table 58. Clinical Genomics Colorectal Cancer Diagnosis and Therapeutics Product

Table 59. Clinical Genomics Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2020-2025) & (US$ Million)

Table 60. Clinical Genomics Recent Development

Table 61. Volition RX Company Details

Table 62. Volition RX Business Overview

Table 63. Volition RX Colorectal Cancer Diagnosis and Therapeutics Product

Table 64. Volition RX Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2020-2025) & (US$ Million)

Table 65. Volition RX Recent Development

Table 66. EDP Biotech Company Details

Table 67. EDP Biotech Business Overview

Table 68. EDP Biotech Colorectal Cancer Diagnosis and Therapeutics Product

Table 69. EDP Biotech Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2020-2025) & (US$ Million)

Table 70. EDP Biotech Recent Development

Table 71. Epigenomics Company Details

Table 72. Epigenomics Business Overview

Table 73. Epigenomics Colorectal Cancer Diagnosis and Therapeutics Product

Table 74. Epigenomics Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2020-2025) & (US$ Million)

Table 75. Epigenomics Recent Development

Table 76. Novigenix Company Details

Table 77. Novigenix Business Overview

Table 78. Novigenix Colorectal Cancer Diagnosis and Therapeutics Product

Table 79. Novigenix Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2020-2025) & (US$ Million)

Table 80. Novigenix Recent Development

Table 81. Siemens Company Details

Table 82. Siemens Business Overview

Table 83. Siemens Colorectal Cancer Diagnosis and Therapeutics Product

Table 84. Siemens Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2020-2025) & (US$ Million)

Table 85. Siemens Recent Development

Table 86. Quest Diagnostics Company Details

Table 87. Quest Diagnostics Business Overview

Table 88. Quest Diagnostics Colorectal Cancer Diagnosis and Therapeutics Product

Table 89. Quest Diagnostics Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2020-2025) & (US$ Million)

Table 90. Quest Diagnostics Recent Development

Table 91. Metabiomics Company Details

Table 92. Metabiomics Business Overview

Table 93. Metabiomics Colorectal Cancer Diagnosis and Therapeutics Product

Table 94. Metabiomics Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2020-2025) & (US$ Million)

Table 95. Metabiomics Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

Table 99. Authors List of This Report

List of Figures

Figure 1. Colorectal Cancer Diagnosis and Therapeutics Picture

Figure 2. Global Colorectal Cancer Diagnosis and Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Colorectal Cancer Diagnosis and Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Diagnostics Features

Figure 5. Therapeutics Features

Figure 6. Global Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Colorectal Cancer Diagnosis and Therapeutics Market Share by Application: 2024 VS 2031

Figure 8. Hospitals Case Studies

Figure 9. Diagnostic centres Case Studies

Figure 10. Research institutions Case Studies

Figure 11. Colorectal Cancer Diagnosis and Therapeutics Report Years Considered

Figure 12. Global Colorectal Cancer Diagnosis and Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Colorectal Cancer Diagnosis and Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Colorectal Cancer Diagnosis and Therapeutics Market Share by Region: 2024 VS 2031

Figure 15. Global Colorectal Cancer Diagnosis and Therapeutics Market Share by Players in 2024

Figure 16. Global Top Colorectal Cancer Diagnosis and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Diagnosis and Therapeutics as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Colorectal Cancer Diagnosis and Therapeutics Revenue in 2024

Figure 18. North America Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Colorectal Cancer Diagnosis and Therapeutics Market Share by Country (2020-2031)

Figure 20. United States Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Colorectal Cancer Diagnosis and Therapeutics Market Share by Country (2020-2031)

Figure 24. Germany Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Share by Region (2020-2031)

Figure 32. China Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Colorectal Cancer Diagnosis and Therapeutics Market Share by Country (2020-2031)

Figure 40. Mexico Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Share by Country (2020-2031)

Figure 44. Turkey Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Abbott Revenue Growth Rate in Colorectal Cancer Diagnosis and Therapeutics Business (2020-2025)

Figure 48. Beckman Coulter Revenue Growth Rate in Colorectal Cancer Diagnosis and Therapeutics Business (2020-2025)

Figure 49. Clinical Genomics Revenue Growth Rate in Colorectal Cancer Diagnosis and Therapeutics Business (2020-2025)

Figure 50. Volition RX Revenue Growth Rate in Colorectal Cancer Diagnosis and Therapeutics Business (2020-2025)

Figure 51. EDP Biotech Revenue Growth Rate in Colorectal Cancer Diagnosis and Therapeutics Business (2020-2025)

Figure 52. Epigenomics Revenue Growth Rate in Colorectal Cancer Diagnosis and Therapeutics Business (2020-2025)

Figure 53. Novigenix Revenue Growth Rate in Colorectal Cancer Diagnosis and Therapeutics Business (2020-2025)

Figure 54. Siemens Revenue Growth Rate in Colorectal Cancer Diagnosis and Therapeutics Business (2020-2025)

Figure 55. Quest Diagnostics Revenue Growth Rate in Colorectal Cancer Diagnosis and Therapeutics Business (2020-2025)

Figure 56. Metabiomics Revenue Growth Rate in Colorectal Cancer Diagnosis and Therapeutics Business (2020-2025)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-9U20281

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global AI Contouring Software for Radiotherapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32T20006

Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Cell Senescence β-Galactosidase Staining Kit Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0Q20500

Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Kinase Inhibitors For Cancer Treatment Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-18V16958

Wed Nov 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Colorectal Cancer Diagnosis and Therapeutics Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-29L15989

Global Colorectal Cancer Diagnosis and Therapeutics Market Research Report 2025

FEATURED COMPANIES

Colorectal Cancer Diagnosis and Therapeutics Market

Scope of Colorectal Cancer Diagnosis and Therapeutics Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Colorectal Cancer Diagnosis and Therapeutics Market report?

What are the Application segmentation covered in the Colorectal Cancer Diagnosis and Therapeutics Market report?

What are the Type segmentation covered in the Colorectal Cancer Diagnosis and Therapeutics Market report?

FEATURED COMPANIES

RELATED REPORTS